The United States Patent and Trademark Office (USPTO) has issued patent US12584163B2, titled 'Compositions and methods for evaluating genomic alterations,' to Foundation Medicine, Inc. The patent, which was filed on June 11, 2019, and granted on March 24, 2026, covers specific compositions and methods related to the evaluation of genomic alterations within biological samples.

This patent grant is primarily relevant to entities involved in genomic analysis, diagnostics, and related research and development. While it does not impose direct regulatory obligations, it establishes intellectual property rights that may affect the commercial activities of other companies in the biotechnology and pharmaceutical sectors, particularly those working with similar technologies. Compliance officers should be aware of this patent's existence as it pertains to their company's R&D or product development in the area of genomic evaluation.